Mabion (FRA:272) Cyclically Adjusted FCF per Share: €-0.76 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:272 Mabion SA FRA:272
26 GF Score
Price €1.64
GF Value €0.47
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mabion Cyclically Adjusted FCF per Share?

Mabion FRA:272 +0.49% 26 Cyclically Adjusted FCF per Share is €-0.76 as of Mar. 2026. GuruFocus rates FRA:272 with a GF Score™ of 26/100 and a GF Value™ of €0.47 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mabion's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.170. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.76 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Mabion was 12.90% per year. The lowest was 6.70% per year. And the median was 9.80% per year.

As of today (2026-07-17), Mabion's current stock price is €1.642. Mabion's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.76. Mabion's Cyclically Adjusted Price-to-FCF of today is .


Mabion  (FRA:272) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mabion Cyclically Adjusted FCF per Share Related Terms


Mabion Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Mabion's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mabion Cyclically Adjusted FCF per Share Chart

Mabion Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.01 -1.04 -1.06 -0.87 -0.75

Mabion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.90 -0.86 -0.76 -0.75 -0.76

FRA:272 vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Mabion's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabion Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabion's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mabion's Cyclically Adjusted Price-to-FCF falls into.


FRA:272
26GF Score
Mabion SA FRA:272
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mabion Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mabion's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.17/163.0700*163.0700
=-0.170

Current CPI (Mar. 2026) = 163.0700.

Mabion Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.359 99.552 -0.588
201609 -0.076 99.064 -0.125
201612 0.177 100.366 0.288
201703 -0.274 101.018 -0.442
201706 -0.276 101.180 -0.445
201709 -0.415 101.343 -0.668
201712 -0.222 102.564 -0.353
201803 -0.379 102.564 -0.603
201806 -0.297 103.378 -0.468
201809 0.005 103.378 0.008
201812 -0.157 103.785 -0.247
201903 -0.287 104.274 -0.449
201906 -0.152 105.983 -0.234
201909 -0.105 105.983 -0.162
201912 -0.171 107.123 -0.260
202003 -0.192 109.076 -0.287
202006 -0.112 109.402 -0.167
202009 -0.183 109.320 -0.273
202012 -0.154 109.565 -0.229
202103 0.240 112.658 0.347
202106 -0.711 113.960 -1.017
202109 0.117 115.588 0.165
202112 -0.587 119.088 -0.804
202203 -0.425 125.031 -0.554
202206 0.071 131.705 0.088
202209 -0.086 135.531 -0.103
202212 0.775 139.113 0.908
202303 0.232 145.950 0.259
202306 -0.429 147.009 -0.476
202309 -0.081 146.113 -0.090
202312 -0.291 147.741 -0.321
202403 0.217 149.044 0.237
202406 0.329 150.997 0.355
202409 -0.040 153.439 -0.043
202412 -0.119 154.660 -0.125
202503 -0.207 157.021 -0.215
202506 -0.178 157.509 -0.184
202509 -0.084 158.000 -0.087
202512 -0.132 158.320 -0.136
202603 -0.170 163.070 -0.170

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.76 mean?
Mabion (FRA:272) has a Cyclically Adjusted FCF per Share of €-0.76 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mabion and its competitors.
Is Mabion's Cyclically Adjusted FCF per Share too high?
Mabion's current Cyclically Adjusted FCF per Share is €-0.76. Overall, Mabion has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mabion's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Mabion's Cyclically Adjusted FCF per Share of €-0.76 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mabion and its competitors. Mabion's current Cyclically Adjusted FCF per Share is €-0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mabion stock overvalued right now?
Based on GuruFocus' analysis, Mabion (FRA:272) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.47, compared to a current price of €1.64 — trading 249.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.76. Mabion's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Mabion (FRA:272), the current Cyclically Adjusted FCF per Share is €-0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mabion (FRA:272) Overvalued in 2026?

Based on GuruFocus' analysis, Mabion stock appears to be overvalued. The current stock price of €1.64 is trading 249.4% above its estimated GF Value™ of €0.47. GuruFocus considers Mabion to be Significantly Overvalued.

Key valuation signals for FRA:272:

  • Cyclically Adjusted FCF per Share: €-0.76
  • GF Value™: €0.47 vs. price of €1.64 (249.4% above fair value)
  • GF Score™: 26/100 with 4 warning signs

No single metric tells the full story. See the FRA:272 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mabion Business Description

Other Exchanges MAB:Poland
Address ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050
Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.
26GF Score

Get the complete analysis for FRA:272

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.64
Price
€0.47
GF Value